AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32957959 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit (context-dependent repetition from prompts and cues) + planning + education condition
Number of subjects: 150
Study 32957959 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental co-activity habit, parent-child co-activity, and other behavioral constructs
Number of subjects: 150
Study 32957959 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental PA
Number of subjects: 150
Study 32957959 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-activity
Number of subjects: 150
Study 36072931 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100mg per day)
Number of subjects: 68
Study 36072931 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500mg three times per day)
Number of subjects: 68
Study 36072931 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin plus Metformin (100mg sitagliptin and 500mg metformin three times per day)
Number of subjects: 68
Study 36072931 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 68
Study 32828880 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 450
Study 32828880 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 450
Study 32828880 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 450
Study 33144278 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 0
Study 33144278 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34579068 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (MCP® BCMC® strains) for 6 months
Number of subjects: 39
Study 34579068 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 39
Study 32386720 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir (400 mg twice daily)
Number of subjects: 408
Study 32386720 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz (600 mg each night)
Number of subjects: 408
Study 32386720 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 408
Study 32386720 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 408
Study 36309743 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal natural orifice specimen extraction (NOSE)
Number of subjects: 38
Study 34118179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirepemat 350 mg single dose
Number of subjects: 44
Study 34118179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirepemat 100 mg multiple doses (3 times daily for 7 days)
Number of subjects: 44
Study 34118179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirepemat 250 mg multiple doses (3 times daily for 7 days)
Number of subjects: 44
Study 34118179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirepemat (all doses)
Number of subjects: 44
Study 34118179 — intervention group
Group type: COMPARATOR
Intervention: Food intake
Number of subjects: 44
Study 32113625 — intervention group
Group type: COMPARATOR
Intervention: Monetary incentive of 10 SGD for completing a questionnaire
Number of subjects: 4000
Study 32113625 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive of 20 SGD for completing a questionnaire and vaccination
Number of subjects: 4000
Study 32113625 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive of 30 SGD for completing a questionnaire and vaccination
Number of subjects: 4000
Study 32113625 — intervention group
Group type: COMPARATOR
Intervention: Monetary incentive of 10 SGD for completing a questionnaire and vaccination
Number of subjects: 4000
Study 35184101 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitally fabricated removable dental prostheses
Number of subjects: 0
Study 35184101 — intervention group
Group type: COMPARATOR
Intervention: Conventionally manufactured removable dental prostheses
Number of subjects: 0
Study 33248884 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of consistency/inconsistency flags to PSP ratings
Number of subjects: 18000
Study 33248884 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of flags to clinical ratings
Number of subjects: 18000
Study 35862774 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrally procured school food program
Number of subjects: 2443
Study 35862774 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's fruit and vegetable consumption
Number of subjects: 2443
Study 33904966 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain cognitive training (CT)
Number of subjects: 64
Study 33904966 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity physical activity training (PT)
Number of subjects: 64
Study 35348246 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for postoperative severe ALI based on variables including coronary heart disease, cardiopulmonary bypass (CPB) ≥ 257.5 min, left atrium diameter ≥ 35.5 mm, hemoglobin ≤ 139.5 g/L, preCPB OI ≤ 100 mmHg, intensive care unit OI ≤ 100 mmHg, left ventricular posterior wall thickness ≥ 10.5 mm, neutrophilic granulocyte percentage ≥ 0.824.
Number of subjects: 479
Study 32640940 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Hemodynamic Therapy (GDHT)
Number of subjects: 108
Study 32640940 — intervention group
Group type: COMPARATOR
Intervention: Standard Clinical Care (Control)
Number of subjects: 108
Study 36435732 — intervention group
Group type: EXPERIMENTAL
Intervention: GLS-guided cardioprotection (CPT)
Number of subjects: 331
Study 36435732 — intervention group
Group type: COMPARATOR
Intervention: EF-guided cardioprotection (CPT)
Number of subjects: 331
Study 33880884 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage for 3 minutes with baby oil
Number of subjects: 128
Study 33880884 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting for 3 minutes)
Number of subjects: 128
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingers
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Left fingers and feet
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Left fingers and wrists
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Left fingers and shoulders
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Left fingers and calves
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingers and feet
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrists
Number of subjects: 115
Study 32931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeatability investigation
Number of subjects: 115
Study 33198533 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 agency assignment
Number of subjects: 207
Study 33198533 — intervention group
Group type: COMPARATOR
Intervention: Human agency assignment
Number of subjects: 207
Study 33198533 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference point (self/self-other)
Number of subjects: 207
Study 33198533 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between agency assignment and reference point
Number of subjects: 207
Study 32597617 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Postural Re-education (GPR)
Number of subjects: 24
Study 32597617 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching on Whole-Body Vibration (WBV)
Number of subjects: 24
Study 32597617 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 24
Study 36380306 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 40 mg starting 12 hours after surgery
Number of subjects: 150
Study 36380306 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral portable IPCD used 24 hours/day on the operated leg for 10 days
Number of subjects: 150
Study 32070335 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c < 6.5%
Number of subjects: 1328
Study 32070335 — intervention group
Group type: COMPARATOR
Intervention: HbA1c 7.0-7.5%
Number of subjects: 1328
Study 32070335 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c 6.5-7.0%
Number of subjects: 1328
Study 32070335 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c 7.5-8.5%
Number of subjects: 1328
Study 32070335 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c ≥ 8.5%
Number of subjects: 1328
Study 35696684 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 1600
Study 35696684 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1600
Study 35696684 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia and General anesthesia
Number of subjects: 1600
Study 33852204 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial triple therapy with metformin, pioglitazone, and exenatide
Number of subjects: 104
Study 33852204 — intervention group
Group type: COMPARATOR
Intervention: Stepwise conventional therapy with metformin followed by glipizide and then glargine insulin
Number of subjects: 104
Study 33852204 — intervention group
Group type: EXPERIMENTAL
Intervention: CPEP120/CPEP0 ratio of more than 1.7
Number of subjects: 104
Study 33852204 — intervention group
Group type: EXPERIMENTAL
Intervention: CPEP120/CPEP0 of less than 1.7 plus FPG of 269 mg/dL or less
Number of subjects: 104
Study 32392422 — intervention group
Group type: EXPERIMENTAL
Intervention: Water to maintain hydration
Number of subjects: 11
Study 32392422 — intervention group
Group type: COMPARATOR
Intervention: No fluid (1.7% ± 0.3% body mass loss)
Number of subjects: 11
Study 33511963 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 785
Study 33511963 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification cataract surgery (PCS)
Number of subjects: 785
Study 32176392 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental theory group (IT)
Number of subjects: 44
Study 32176392 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental theory plus success criteria group (IT + SC)
Number of subjects: 44
Study 32176392 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 35839791 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (1.5 g cefuroxime, intramuscular in Norway or intravenous in Germany)
Number of subjects: 555
Study 35839791 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 555
Study 35549505 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 0
Study 35549505 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study 35549505 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 33032837 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Portfolio Diet (Diet2)
Number of subjects: 60
Study 33032837 — intervention group
Group type: COMPARATOR
Intervention: Low saturated fat diet (Diet1)
Number of subjects: 60
Study 35880252 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery with fast-acting insulin aspart
Number of subjects: 45
Study 35880252 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin therapy (control group)
Number of subjects: 45
Study 33763879 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (walking combined with jogging) for 60 minutes per day, 5 days a week for 8 weeks
Number of subjects: 60
Study 32695815 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin-thrombin matrix sealant (GTMS)
Number of subjects: 206
Study 32695815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GTMS)
Number of subjects: 206
Study 33856856 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 224
Study 33856856 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychoanalytic psychotherapy
Number of subjects: 224
Study 33856856 — intervention group
Group type: COMPARATOR
Intervention: Brief psychosocial intervention
Number of subjects: 224
Study 32072651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' empathic tendencies
Number of subjects: 472
Study 32072651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' empathic skills
Number of subjects: 472
Study 35954810 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid cardiovascular rehabilitation program (first 5 days in rehabilitation centre, then in sport centres)
Number of subjects: 60
Study 35954810 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation program in a rehabilitation centre
Number of subjects: 60
Study 34726850 — intervention group
Group type: COMPARATOR
Intervention: Astra Tech implants (group A)
Number of subjects: 18
Study 34726850 — intervention group
Group type: COMPARATOR
Intervention: Brånemark implants (group B)
Number of subjects: 18
Study 32833481 — intervention group
Group type: EXPERIMENTAL
Intervention: WLM + EFT
Number of subjects: 0
Study 32833481 — intervention group
Group type: COMPARATOR
Intervention: WLM-STD
Number of subjects: 0
Study 36436017 — intervention group
Group type: EXPERIMENTAL
Intervention: SSSH (Structured Supervised Strength Training)
Number of subjects: 60
Study 36436017 — intervention group
Group type: COMPARATOR
Intervention: Walk
Number of subjects: 60
Study 36436017 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 32331076 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine (ESK) + oral antidepressant (AD)
Number of subjects: 176
Study 32331076 — intervention group
Group type: COMPARATOR
Intervention: Oral antidepressant (AD) + intranasal placebo
Number of subjects: 176
Study 32331076 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ‐9 items #1, #2, #4, #6
Number of subjects: 176
Study 35167059 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 81
Study 35167059 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 81
Study 35167059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 33226186 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure variability (BPV) measurements during the subacute phase
Number of subjects: 832
Study 35545446 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE‐083 (240 mg/muscle injected bilaterally in the tibialis anterior muscle)
Number of subjects: 63
Study 35545446 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE‐083
Number of subjects: 63
Study 35545446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 34157878 — intervention group
Group type: EXPERIMENTAL
Intervention: Beyond Violence (BV) program, 20 sessions
Number of subjects: 145
Study 34157878 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WC)
Number of subjects: 145
Study 32780476 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic pulses with phase durations (PD) 200µs and an interphase interval (IPI) of 200µs
Number of subjects: 18
Study 32780476 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic pulses with phase durations (PD) 500µs and an interphase interval (IPI) of 200µs
Number of subjects: 18
Study 32780476 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic pulses with phase duration (PD) 200µs
Number of subjects: 18
Study 32780476 — intervention group
Group type: COMPARATOR
Intervention: Biphasic pulses with phase durations (PD) 200µs or 500µs without an IPI
Number of subjects: 18
Study 36403124 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic RCTs assessing balancing
Number of subjects: 86
Study 36403124 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical significance testing for baseline characteristics
Number of subjects: 86
Study 36403124 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcome measures (PROMs)
Number of subjects: 86
Study 36403124 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PROM values reported
Number of subjects: 86
Study 36403124 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference in baseline PROM values between groups
Number of subjects: 86
Study 33010116 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester (KM) ingestion
Number of subjects: 9
Study 32989872 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone-pioglitazone-metformin (SPIOMET)
Number of subjects: 30
Study 32989872 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC)
Number of subjects: 30
Study 32989872 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched girls)
Number of subjects: 30
Study 32299024 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 40 mg/day
Number of subjects: 46
Study 32299024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 36008143 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (1 mg/kg for 10 days)
Number of subjects: 187
Study 36008143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 34187420 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical care including regular, individualized telephone calls and SMS-messages
Number of subjects: 118
Study 34187420 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 118
Study 33543476 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater palatine compression suture (GPCS)
Number of subjects: 24
Study 33543476 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 32571277 — intervention group
Group type: EXPERIMENTAL
Intervention: Private facilities
Number of subjects: 300
Study 32571277 — intervention group
Group type: COMPARATOR
Intervention: Public facilities
Number of subjects: 300
Study 32571277 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket healthcare expenditure ≥USD 30
Number of subjects: 300
Study 32571277 — intervention group
Group type: COMPARATOR
Intervention: Out-of-pocket healthcare expenditure ≤USD 5
Number of subjects: 300
Study 32571277 — intervention group
Group type: EXPERIMENTAL
Intervention: Male-headed households
Number of subjects: 300
Study 32571277 — intervention group
Group type: COMPARATOR
Intervention: Female-headed households
Number of subjects: 300
Study 35908042 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mA tDCS
Number of subjects: 0
Study 35908042 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 32926748 — intervention group
Group type: EXPERIMENTAL
Intervention: Irsogladine maleate (IM) 4 mg/day for 12 weeks
Number of subjects: 24
Study 32926748 — intervention group
Group type: EXPERIMENTAL
Intervention: Irsogladine maleate (IM)
Number of subjects: 24
Study 32926748 — intervention group
Group type: COMPARATOR
Intervention: Non-administration group
Number of subjects: 24
Study 32810748 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 373
Study 32810748 — intervention group
Group type: EXPERIMENTAL
Intervention: FBXW7 mutations
Number of subjects: 373
Study 32810748 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI-H tumours
Number of subjects: 373
Study 36004519 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (120-minute sessions once a week for four weeks)
Number of subjects: 64
Study 36004519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 64
Study 33990648 — intervention group
Group type: EXPERIMENTAL
Intervention: Tria Ureteral Stent
Number of subjects: 84
Study 33990648 — intervention group
Group type: COMPARATOR
Intervention: Polaris Ultra Ureteral Stent
Number of subjects: 84
Study 33990648 — intervention group
Group type: EXPERIMENTAL
Intervention: Both stents
Number of subjects: 84
Study 33990648 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical factors
Number of subjects: 84
Study 32546554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg daily as maintenance therapy
Number of subjects: 90
Study 32546554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 34010934 — intervention group
Group type: COMPARATOR
Intervention: Topical estrogen therapy (n=12)
Number of subjects: 25
Study 34010934 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy (n=13)
Number of subjects: 25
Study 35543701 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (PCSK9 inhibitor)
Number of subjects: 11880
Study 35543701 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine kinase levels during statin treatment
Number of subjects: 11880
Study 35543701 — intervention group
Group type: EXPERIMENTAL
Intervention: p.Val174Ala (rs4149056) in SLCO1B1
Number of subjects: 11880
Study 32299241 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) plus electroacupuncture (EA) for 6 weeks
Number of subjects: 120
Study 32299241 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (sham MA plus sham EA) for 6 weeks
Number of subjects: 120
Study 32122325 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise and cognitive training (EXCOG)
Number of subjects: 74
Study 32122325 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (EX)
Number of subjects: 74
Study 32122325 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (COG)
Number of subjects: 74
Study 32122325 — intervention group
Group type: COMPARATOR
Intervention: Video-watching control (CON)
Number of subjects: 74
Study 35757477 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine
Number of subjects: 66
Study 35757477 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine + Lidocaine
Number of subjects: 66
Study 35757477 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 66
Study 32419559 — intervention group
Group type: EXPERIMENTAL
Intervention: Biotin supplementation prescribed by physicians
Number of subjects: 149
Study 32419559 — intervention group
Group type: EXPERIMENTAL
Intervention: Other biotin-containing supplements recommended by physicians
Number of subjects: 149
Study 32419559 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of randomized studies on biotin
Number of subjects: 149
Study 32419559 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of biotin interference with laboratory tests
Number of subjects: 149